Scholarlink

Purpose of Review <p>Over the years, the European Organization for Research and Treatment of Cancer (EORTC) has played a key role in defining and updating diagnostic criteria for invasive fungal infections (IFIs). This 22-year review synthesizes the evolution of consensus definitions for fungal diseases highlighting key changes and their implications for clinical practice and research.</p> Recent Findings <p>The first consensus in 2002 introduced standardized criteria for diagnosing IFIs. Subsequent revisions (2008, 2020) incorporated advances in diagnostic methods. The 2021 and 2024 updates expanded definitions to include critically ill, non-neutropenic intensive care unit patients, refining criteria for invasive candidiasis and aspergillosis while excluding endemic mycoses.</p> Summary <p>The evolution of consensus definitions has significantly enhanced the understanding and diagnosis of IFIs, contributing to improved patient care and research standardization. Challenges remain in non-classically immunocompromised populations and in integrating molecular diagnostics into routine practice. Continuous updates and global collaborations are essential to improve IFIs detection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Consensus Criteria for Invasive Fungal Infections: A 22-Year Review of EORTC Definitions

  • 期刊论文

  • 发表日期：

    2025年6月21日

查看全文
  • Giulianna Pereira Tizzot,
  • Leonardo Pinho Carreño,
  • Marcello Mihailenko Chaves Magri,
  • Giovanni Luís Breda,
  • Francisco Beraldi-Magalhaes,
  • Flávio de Queiroz-Telles,
  • Francelise Bridi Cavassin

摘要

Purpose of Review

Over the years, the European Organization for Research and Treatment of Cancer (EORTC) has played a key role in defining and updating diagnostic criteria for invasive fungal infections (IFIs). This 22-year review synthesizes the evolution of consensus definitions for fungal diseases highlighting key changes and their implications for clinical practice and research.

Recent Findings

The first consensus in 2002 introduced standardized criteria for diagnosing IFIs. Subsequent revisions (2008, 2020) incorporated advances in diagnostic methods. The 2021 and 2024 updates expanded definitions to include critically ill, non-neutropenic intensive care unit patients, refining criteria for invasive candidiasis and aspergillosis while excluding endemic mycoses.

Summary

The evolution of consensus definitions has significantly enhanced the understanding and diagnosis of IFIs, contributing to improved patient care and research standardization. Challenges remain in non-classically immunocompromised populations and in integrating molecular diagnostics into routine practice. Continuous updates and global collaborations are essential to improve IFIs detection.